Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

MeVis Medical Solutions AG. (12/17/14). "Press Release: Executive Board and Supervisory Board welcome public takeover offer of VMS Deutschland Holdings GmbH [Ad hoc announcement]". Bremen.

Organisations Organisation MeVis Medical Solutions AG
  Group Varian Medical Systems (Group)
  Organisation 2 VMS Deutschland Holdings GmbH
  Group Varian Medical Systems (Group)
Products Product MeVisLab™ software platform
  Product 2 medical device
Index term Index term MeVis–Varian Medical Systems: investment, 201412–201504 public cash tender offer €30m with €17.5/share

Today, VMS Deutschland Holdings GmbH based in Darmstadt, an affiliate of Varian Medical Systems, Inc., Palo Alto, California, USA, has published pursuant to Section 10 WpÜG its decision to make a voluntary public takeover offer to all shareholders of MeVis Medical Solutions AG to acquire their registered non-par value shares against payment of EUR 17.50 per share. The offer is intended to be subject to the condition of a minimum acceptance rate of 75 % of the shares issued by MeVis Medical Solutions AG (excluding treasury shares).

According to the VMS Deutschland Holdings GmbH a number of major shareholders have irrevocably undertaken to accept the offer of the VMS Deutschland Holdings GmbH; this corresponds to a total of over 70 % of the shares issued by the MeVis Medical Solutions AG (excluding treasury shares).

The Executive Board and Supervisory Board of the MeVis Medical Solutions AG will carefully review the offer and publish a statement pursuant to § 27 WpÜG within two weeks after publication of the offer document. According to their initial assessment the Executive Board and Supervisory Board welcome the offer in principal and consider Varian Medical Systems a reliable partner for the further development of the MeVis Medical Solutions AG.

Varian Medical Systems is the world's leading manufacturer of medical devices and software for treating cancer and other diseases through radiotherapy, proton therapy, and brachytherapy.

Record changed: 2017-04-02


Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Varian Medical Systems (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top